Cargando…
Setting the scene – a future ‘epidemic’ of immune-related adverse events in association with checkpoint inhibitor therapy
Cancer immune therapy with checkpoint inhibitors (CPIs) has changed the landscape of treatment for a growing number of indications. These drugs are associated with a specific mechanism of action that has profound implications for both immunology and inflammatory disease. This article looks to set th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900909/ https://www.ncbi.nlm.nih.gov/pubmed/31816083 http://dx.doi.org/10.1093/rheumatology/kez402 |